Coronary CT angiography

Life Guard Imaging Named Official Tent Sponsor for The Mike Evans Charity Golf Outing

Retrieved on: 
Thursday, June 15, 2023
Social responsibility, Business development, Partnership, Education, Business, Aşlı, Golf, Michael Evans, Tampa Bay Buccaneers, Coronary CT angiography, Sport, LGI, Tourism

TAMPA, Fla., June 15, 2023 /PRNewswire/ -- Life Guard Imaging, a leading provider of advanced preventative screenings, is pleased to announce its partnership as an official tent sponsor for The Mike Evans Charity Golf Outing, a notable fundraising event to benefit The Mike Evans Family Foundation.

Key Points: 
  • TAMPA, Fla., June 15, 2023 /PRNewswire/ -- Life Guard Imaging, a leading provider of advanced preventative screenings, is pleased to announce its partnership as an official tent sponsor for The Mike Evans Charity Golf Outing, a notable fundraising event to benefit The Mike Evans Family Foundation.
  • Life Guard Imaging's decision to become an official tent sponsor of The Mike Evans Charity Golf Outing highlights its dedication to philanthropy and social responsibility.
  • "We are honored to be one of the official tent sponsors for The Mike Evans Charity Golf Outing and to support The Mike Evans Family Foundation," said Martin Gramatica, VP of Business Development at Life Guard Imaging.
  • As an official tent sponsor, Life Guard Imaging allowed participants to sign up for a complimentary Coronary CT scan.

Recent Study Demonstrates Leveraging ECV-CTA Assessment from Routine TAVR Evaluation Correlates Well with ECV-CMR and Has Significant Methodological Implications

Retrieved on: 
Tuesday, July 19, 2022
Cardiac amyloidosis, Acquisition, Congress, Abraxis BioScience, Structure, Weeping Angel, Patient, Coronary, Solution, CCTA, Aortic stenosis, Coronary CT angiography, Technology, Pulmonary fibrosis, Deep learning, Ownership, Workflow, Map, ImmunityBio, CMR, Marketing, ECV, Society, Aortic valve, Efficiency, Risk, TAVR, SCCT, The San Diego Union-Tribune, CT, Abbott Northwestern Hospital, Population, Medical imaging, NantWorks, MD

NEWARK, Calif., July 19, 2022 /PRNewswire-PRWeb/ -- A study abstract published at the annual Society of Cardiac Computed Tomography (SCCT) congress last week indicated an excellent correlation of extracellular volume fraction (ECV) computed tomography (CT) with ECV cardiac magnetic resonance (CMR) in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) and had significant methodological implications. The pilot research study from Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital utilized a commonly available prospective ECG-gated acquisition, which provided reliable imaging quality for ECV-CT analysis using Ziosoft, one of the only commercially available ECV-CT solutions.

Key Points: 
  • This technology helped enable ECV-CT assessment making it a viable, non-invasive approach for non-invasive assessment of myocardial fibrosis and potential pre-screening of Cardiac Amyloidosis during a pre-planning TAVR or post-TAVR procedure."
  • CT TAVR planning also can evaluate ECV to indicate the presence of concomitant cardiac amyloidosis, which can be as frequent as 12-15% in this elderly population.
  • "With the U.S. performing more than 73,000 TAVR procedures annually, the findings of this study could be significant," said Rajeev Taitriya, vice president of marketing and business development for Ziosoft.
  • We are pleased to be a part of this and many other studies showing the power of Ziosoft technology."

Ziosoft to Feature ECVct and LAAO Advanced Visualization at American College of Cardiology Annual Convention

Retrieved on: 
Friday, April 1, 2022
Disease, ACC, Heart, Marketing, The San Diego Union-Tribune, TAVR, AV, Coronary CT angiography, Ownership, Left atrial appendage occlusion, Abraxis BioScience, Amyloid, Program, Pathology, Percutaneous aortic valve replacement, Atrial appendage, Man, MD, Woman, ECV, Stroke, American College, ImmunityBio, Coronary, Weeping Angel, Solution, Atrial fibrillation, Amyloidosis, Efficiency, Protein, Patient, CCTA, Decision-making, Medical imaging, NantWorks

NEWARK, Calif., April 1, 2022 /PRNewswire-PRWeb/ -- Ziosoft, a pioneer and leader in 3D/4D advanced visualization, will feature its ECVct (Extracellular Volume Fraction with computed tomography) and LAAO (Left Atrial Appendage Occlusion) advanced visualization (AV) software at the annual American College of Cardiology (ACC) conference being held in Washington DC, April 2-4, 2022. Both capabilities are part of Ziosoft's extensive array of AV solutions for multiple applications and modalities on its flagship Ziostation2 platform.

Key Points: 
  • NEWARK, Calif., April 1, 2022 /PRNewswire-PRWeb/ -- Ziosoft, a pioneer and leader in 3D/4D advanced visualization, will feature its ECVct (Extracellular Volume Fraction with computed tomography) and LAAO (Left Atrial Appendage Occlusion) advanced visualization (AV) software at the annual American College of Cardiology (ACC) conference being held in Washington DC, April 2-4, 2022.
  • In addition to ECVct and LAAO, Ziosoft will be demonstrating its unique PhyZiodynamics 3D/4D solution as well as CT lung resection software.
  • "Zioflex enables a risk free entry into the utilization of highly advanced visualization and analytics contained within the Ziosoft platform," said Taitriya.
  • Ziosoft provides a comprehensive multi-modality, 3D/4D advanced processing and viewing solution for a wide variety of specialties.

SeqLL Announces Publication of a New Blood-Based RNA Sequencing Method to Detect Coronary Artery Disease

Retrieved on: 
Monday, September 27, 2021
Molecule, BioMed Central, Korea Disease Control and Prevention Agency, Nature, PCR, Coronary artery disease, Gene expression, Moyamoya disease, School, Risk, RNA, Regulation, Security (finance), Inova Health System, NASDAQ, Private Securities Litigation Reform Act, U.S. Securities and Exchange Commission, Atherosclerosis, DNA, GW, Patient, Death, CAD, Physician, Single molecule fluorescent sequencing, Independent school district, Biomarker, Gene, SQL, GLOBE, Bias, Form, Autoimmunity, Company, Cardiovascular disease, Disease, Genomics, Artery, COVID-19, Technology, RNA-Seq, Center, Research, George Washington University, Forward-looking statement, Diagnosis, Intellectual property, Washington, Cardiac catheterization, Doctor of Philosophy, Coronary CT angiography, CO, Pharmaceutical industry, Medical imaging, Vaccine

Diagnosis of CAD is typically based on coronary angiography, an imaging process used to detect restricted blood flow in the hearts major arteries.

Key Points: 
  • Diagnosis of CAD is typically based on coronary angiography, an imaging process used to detect restricted blood flow in the hearts major arteries.
  • Using SeqLLs tSMS platform, our team was able to sequence millions of RNA strands per patient at single molecule resolution.
  • This allowed us to reproducibly identify specific RNA transcripts that were altered in patients with coronary disease, Dr. McCaffrey said.
  • This study represents another step toward providing improved, non-invasive diagnostic options to those suffering from coronary artery disease.